Andrew Garbarino
Andrew Garbarino (NY-2) disclosed a net worth range between -$510K and $53K in their 2025 annual filing.
Compare this disclosure with the House of Representatives net worth rankings .
Net worth
Estimated from the ranges in the member's annual financial disclosures: the band runs from the sum of disclosed asset minimums less liability maximums up to the sum of asset maximums less liability minimums. Only electronically filed reports are read — a missing year means no electronic filing, not zero net worth.
Net worth band by reporting year
| Year | Filed | Net worth band |
|---|---|---|
| 2025 | 2026-08-06 | -$510K – $53K |
| 2024 | 2025-08-13 | -$495K – $103K |
| 2023 | 2024-08-13 | -$494K – $118K |
| 2022 | 2023-08-13 | -$472K – $149K |
| 2021 | 2022-08-10 | -$475K – $104K |
Disclosed assets
The assets Andrew Garbarino itemised in their 2025 annual report, largest bracket first. Descriptions are the filer's own wording, and each value is the bracket they checked on the form — never a reported amount.
| Description | Type | Income | Value |
|---|---|---|---|
| MetLife Whole Life Insurance | WU |
Tax-Deferred
|
$50K - $100K |
| Andrew Roth IRA ⇒ American Beacon ARK Transformational Innovation Fund - C Class (ADNCX) | MF |
Tax-Deferred
|
$15K - $50K |
| PennMutual Whole Life | WU |
Tax-Deferred
|
$15K - $50K |
| Andrew Roth IRA ⇒ Roper Technologies, Inc. (ROP) | ST |
Tax-Deferred
|
$1K - $15K |
| Andrew Roth IRA ⇒ The Growth Fund of America Class A Shares (AGTHX) | MF |
Tax-Deferred
|
$1K - $15K |
| Andrew Roth IRA ⇒ Virtus KAR Mid-Cap Core Fund C (VMCCX) | MF |
Tax-Deferred
|
$1K - $15K |
| Andrew Roth IRA ⇒ Zoetis Inc. Class A Common Stock (ZTS) | ST |
Tax-Deferred
|
$1K - $15K |
| Bristol-Myers Squibb Company Common Stock (BMY) | ST |
$1 - $200
Dividends
|
$1K - $15K |
| Capital One Bank Account | BA |
$201 - $1K
Interest
|
$1K - $15K |
| NYS Deferred Compensation Plan 457(b) ⇒ NYS Deferred Compensation Plan 457(b) T Rowe Price Retirement date 2040 Trust | OT |
Tax-Deferred
|
$1K - $15K |
| NYS Deferred Compensation Plan 457(b) ⇒ NYS Deferred Compensation Plan 457(b) T Rowe Price Retirement date 2045 Trust | OT |
Tax-Deferred
|
$1K - $15K |
| NYS Deferred Compensation Plan 457(b) ⇒ NYS Deferred Compensation Plan 457(b) T Rowe Price Retirement date 2050 Trust | OT |
Tax-Deferred
|
$1K - $15K |
| TD Bank Account | BA |
$201 - $1K
Interest
|
$1K - $15K |
| Andrew Roth IRA ⇒ AT&T Inc. (T) | ST |
Tax-Deferred
|
$1 - $1K |
| Andrew Roth IRA ⇒ Intel Corporation - Common Stock (INTC) | ST |
Tax-Deferred
|
$1 - $1K |
| Andrew Roth IRA ⇒ MDU Resources Group, Inc. Common Stock (MDU) | ST |
Tax-Deferred
|
$1 - $1K |
Disclosed liabilities
The liabilities itemised in the 2025 annual report, largest bracket first. These are the amounts subtracted when the net worth band above is rolled up.
| Description | Amount owed |
|---|---|
| Home Mortgage Refinance (Ridgewood Savings Bank) | $250K - $500K |
| Law School Student Loans (Aidvantage) | $50K - $100K |
Recent stock trades
| Date | Stock | Type | Owner | Amount | Filed | Lag |
|---|---|---|---|---|---|---|
| 2025-08-21 | GAP ST · Gap, Inc. (GAP) | Sell | — Stock Account | $1K - $15K | 2025-08-21 | 0d |
| 2022-01-14 | ORMP Oramed Pharmaceuticals Inc. (ORMP) | Sell | — | $1K - $15K | 2022-01-14 | 0d |
| 2022-01-14 | ORMP ST · Oramed Pharmaceuticals Inc. (ORMP) F ILING S TATUS : New S UbHOLDING O F : Stock Account | Sell | — | $1K - $15K | 2022-01-14 | 0d |
| 2022-01-14 | TELL ST · Tellurian Inc. (TELL) F ILING S TATUS : New S UbHOLDING O F : Stock Account | Buy | — | $1K - $15K | 2022-01-14 | 0d |
| 2021-10-01 | OSW OneSpaWorld Holdings Limited - Common Shares (OSW) | Sell | — | $1K - $15K | 2021-11-03 | 33d |
| 2021-10-01 | ORMP Oramed Pharmaceuticals Inc. (ORMP) | Sell | — | $1K - $15K | 2021-11-03 | 33d |
| 2021-10-01 | GPS ST · Gap, Inc. (GPS) F ILING S TATUS : New S UbHOLDING O F : Stock Account | Buy | — | $1K - $15K | 2021-11-03 | 33d |
| 2021-10-01 | OSW ST · OneSpaWorld Holdings Limited - Common Shares (OSW) F ILING S TATUS : New S UbHOLDING O F : Stock Account | Sell | — | $1K - $15K | 2021-11-03 | 33d |
| 2021-10-01 | ORMP ST · Oramed Pharmaceuticals Inc. (ORMP) F ILING S TATUS : New S UbHOLDING O F : Stock Account | Sell | — | $1K - $15K | 2021-11-03 | 33d |
| 2021-10-01 | TELL ST · Tellurian Inc. (TELL) F ILING S TATUS : New S UbHOLDING O F : Stock Account | Buy | — | $1K - $15K | 2021-11-03 | 33d |
| 2021-04-23 | BAC bank of America Corporation (bAC) | Sell | — | $1K - $15K | 2021-05-24 | 31d |
| 2021-04-23 | OSW OneSpaWorld Holdings Limited - Common Shares (OSW) | Buy | — | $1K - $15K | 2021-05-24 | 31d |
| 2021-04-23 | ORMP Oramed Pharmaceuticals Inc. (ORMP) | Buy | — | $1K - $15K | 2021-05-24 | 31d |
| 2021-04-23 | BAC ST · bank of America Corporation (bAC) F ILING S TATUS : New S UbHOLDING O F : Stock Account | Sell | — | $1K - $15K | 2021-05-24 | 31d |
| 2021-04-23 | OSW ST · OneSpaWorld Holdings Limited - Common Shares (OSW) F ILING S TATUS : New S UbHOLDING O F : Stock Account | Buy | — | $1K - $15K | 2021-05-24 | 31d |
| 2021-04-23 | GSS ST · Golden Star Resources, Ltd (GSS) F ILING S TATUS : New S UbHOLDING O F : Stock Account | Sell | — | $1K - $15K | 2021-05-24 | 31d |
| 2021-04-23 | ORMP ST · Oramed Pharmaceuticals Inc. (ORMP) F ILING S TATUS : New S UbHOLDING O F : Stock Account | Buy | — | $1K - $15K | 2021-05-24 | 31d |
Estimated portfolio performance
Price return of the portfolio reconstructed from this member's disclosed trades over each trailing window, versus the S&P 500 (SPY), as of 2026-09-09. Trade sizes are disclosed only as ranges, so every figure is an estimate. Returns use comparable raw closes and exclude dividends; a window crossing a captured split is left unavailable instead of mixing price bases.
| Window | Portfolio | SPY | vs SPY |
|---|---|---|---|
| 1 week | +2.2% | -0.4% | +2.6% |
| 1 month | -14.6% | -1.4% | -13.2% |
| 1 quarter | -6.6% | +3.4% | -10.0% |
| Year to date | +8.0% | +11.8% | -3.8% |
Reconstructed holdings
The portfolio reconstructed from this member's disclosed Purchase and Sale trades: net shares valued at the latest close (2026-09-09). Sizes come from disclosed amount ranges, so share counts, values, and weights are all estimates.
| Stock | Est. shares | Est. value | Weight |
|---|---|---|---|
| OSW | 17 | $371 | 100.0% |